T2 Biosystems to Host Business Update Call on October 10, 2024
T2 Biosystems, a leader in rapid sepsis pathogen and antibiotic resistance gene detection, has announced a business update call scheduled for October 10, 2024, at 4:30pm ET. The call will provide additional details on recent developments and address select shareholder questions submitted in advance to ir@T2Biosystems.com.
Investors can access the call through:
- A live and archived webcast at www.t2biosystems.com (Investors page, Events & Presentations section)
- Dialing 1-888-506-0062 (US/Canada) or 1-973-528-0011 (International) with passcode 702677
Participants are advised to dial in approximately ten to five minutes before the start time.
T2 Biosystems, un leader nella rilevazione rapida di patogeni della sepsi e geni di resistenza agli antibiotici, ha annunciato una call di aggiornamento aziendale programmata per il 10 ottobre 2024 alle 16:30 ET. La chiamata fornirà ulteriori dettagli sugli sviluppi recenti e affronterà alcune domande selezionate degli azionisti inviate in anticipo a ir@T2Biosystems.com.
Gli investitori possono accedere alla chiamata tramite:
- Un webcast dal vivo e archiviato su www.t2biosystems.com (pagina Investitori, sezione Eventi e Presentazioni)
- Chiamando il numero 1-888-506-0062 (USA/Canada) o 1-973-528-0011 (Internazionale) con il codice di accesso 702677
Si consiglia ai partecipanti di chiamare circa dieci a cinque minuti prima dell'orario di inizio.
T2 Biosystems, un líder en la detección rápida de patógenos de sepsis y genes de resistencia a antibióticos, ha anunciado una llamada de actualización empresarial programada para el 10 de octubre de 2024 a las 4:30 PM ET. La llamada proporcionará detalles adicionales sobre desarrollos recientes y abordará algunas preguntas seleccionadas de los accionistas enviadas con antelación a ir@T2Biosystems.com.
Los inversores pueden acceder a la llamada a través de:
- Un webcast en vivo y archivado en www.t2biosystems.com (página de Inversores, sección de Eventos y Presentaciones)
- Marcando 1-888-506-0062 (EE. UU./Canadá) o 1-973-528-0011 (Internacional) con el código de acceso 702677
Se aconseja a los participantes que llamen aproximadamente de diez a cinco minutos antes de la hora de inicio.
T2 Biosystems는 급성 패혈증 병원체 및 항생제 내성 유전자 탐지의 선두주자로서 2024년 10월 10일 오후 4:30 ET에 예정된 사업 업데이트 콜을 발표했습니다. 이번 콜에서는 최근의 개발 사항에 대한 추가 세부정보를 제공하고 ir@T2Biosystems.com으로 사전에 제출된 주주 질문을 다룰 예정입니다.
투자자는 다음을 통해 콜에 참석할 수 있습니다:
- www.t2biosystems.com의 생중계 및 아카이브 웹캐스트(투자자 페이지, 이벤트 및 프레젠테이션 섹션)
- 패스코드 702677을 입력하고 1-888-506-0062(미국/캐나다) 또는 1-973-528-0011(국제)로 전화하기
참여자는 시작 시간 약 10분에서 5분 전에 전화하시기 바랍니다.
T2 Biosystems, un leader dans la détection rapide des agents pathogènes de sepsie et des gènes de résistance aux antibiotiques, a annoncé un appel de mise à jour commerciale prévu pour le 10 octobre 2024 à 16h30 ET. L'appel fournira des détails supplémentaires sur les développements récents et répondra à certaines questions sélectionnées des actionnaires soumises à l'avance à ir@T2Biosystems.com.
Les investisseurs peuvent accéder à l'appel via :
- Un webinaire en direct et archivé sur www.t2biosystems.com (page Investisseurs, section Événements & Présentations)
- En composant le 1-888-506-0062 (États-Unis/Canada) ou le 1-973-528-0011 (International) avec le code d'accès 702677
Il est conseillé aux participants de se connecter environ dix à cinq minutes avant l'heure de début.
T2 Biosystems, ein führendes Unternehmen in der schnellen Erkennung von Sepsispathogenen und Antibiotikaresistenzgenen, hat einen Geschäftsupdate-Anruf für den 10. Oktober 2024 um 16:30 Uhr ET angekündigt. Der Anruf wird weitere Details zu aktuellen Entwicklungen liefern und ausgewählte Fragen von Aktionären beantworten, die im Voraus an ir@T2Biosystems.com gesendet wurden.
Investoren können auf den Anruf zugreifen über:
- Ein Live- und Archiv-Webcast unter www.t2biosystems.com (Investoren-Seite, Abschnitt Veranstaltungen & Präsentationen)
- Durch Wählen von 1-888-506-0062 (USA/Kanada) oder 1-973-528-0011 (International) mit dem Zugangscode 702677
Die Teilnehmer werden gebeten, etwa zehn bis fünf Minuten vor Beginn anzurufen.
- None.
- None.
LEXINGTON, Mass., Oct. 08, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will host a business update call to provide additional details on recent developments after market close at 4:30pm ET on Thursday October 10, 2024. On the call management also plans to address select questions from shareholders that can be submitted in advance to the investor relations team at ir@T2Biosystems.com.
Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.t2biosystems.com, on the Investors page in the Events & Presentations section. To listen to the conference call, please dial 1-888-506-0062 (US/Canada) or 1-973-528-0011 (International), passcode 702677, approximately ten to five minutes prior to the start time.
About T2 Biosystems
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology and include the T2Dx® Instrument, the T2Bacteria® Panel, the T2Candida® Panel, the T2Resistance® Panel, and the T2Biothreat™ Panel. T2 Biosystems has an active pipeline of future products, including the U.S. T2Resistance Panel, the T2Lyme™ Panel, and the expended T2Candida Panel to add the detection of Candida auris. For more information, please visit www.t2biosystems.com.
Investor Contact:
Philip Trip Taylor, Gilmartin Group
ir@T2Biosystems.com
415-937-5406
FAQ
When is T2 Biosystems (TTOO) hosting its business update call?
How can investors listen to T2 Biosystems' (TTOO) business update call?
What topics will T2 Biosystems (TTOO) cover in its October 10, 2024 business update call?
How can shareholders submit questions for T2 Biosystems' (TTOO) business update call?
